News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,464 Results
Type
Article (8055)
Company Profile (140)
Press Release (476364)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166761)
Career Advice (304)
Deals (25749)
Drug Delivery (7)
Drug Development (52881)
Employer Resources (14)
FDA (9762)
Job Trends (8573)
News (238214)
Policy (17898)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33161)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10370)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6964)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3628)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47855)
Collaboration (1239)
Commercialization (3)
Compensation (1449)
Complete response letters (34)
COVID-19 (757)
CRISPR (63)
C-suite (737)
Cystic fibrosis (85)
Data (5626)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73678)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87593)
Executive appointments (698)
FDA (12370)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (910)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9326)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (945)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (42)
IPO (12392)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8652)
Medtech (8792)
Mergers & acquisitions (14387)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1818)
NextGen: Class of 2026 (3155)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41231)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15461)
Phase 2 (21372)
Phase 3 (14397)
Pipeline (7236)
Policy (18)
Postmarket research (1572)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3023)
Recruiting (6)
Regulatory (14802)
Reports (20)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2024)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (2)
Last 7 days (457)
Last 30 days (1611)
Last 365 days (19026)
2026 (12075)
2025 (19251)
2024 (22989)
2023 (26540)
2022 (34591)
2021 (37185)
2020 (33480)
2019 (23256)
2018 (17498)
2017 (18766)
2016 (17922)
2015 (24265)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17884)
Australia (2097)
California (11906)
Canada (3127)
China (517)
Colorado (481)
Connecticut (407)
Delaware (207)
Europe (24628)
Florida (1780)
Georgia (375)
Hawaii (3)
Idaho (46)
Illinois (696)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1193)
Massachusetts (7825)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2610)
New Mexico (12)
New York (2811)
North Carolina (1268)
North Dakota (4)
Northern California (5961)
Ohio (276)
Oklahoma (14)
Oregon (18)
Pennsylvania (2244)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4942)
Tennessee (119)
Texas (1925)
United States (38679)
Utah (358)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (921)
West Virginia (1)
Wisconsin (73)
484,464 Results for "humacyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
·
21 min read
Press Releases
Humacyte, Inc. Announces Proposed Public Offering of Common Stock - June 10, 2026
June 11, 2026
·
5 min read
Press Releases
Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026
August 9, 2026
·
5 min read
Press Releases
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting
July 27, 2026
·
7 min read
Press Releases
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access
July 14, 2026
·
8 min read
Press Releases
Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer
May 12, 2026
·
7 min read
Press Releases
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
April 22, 2026
·
8 min read
Press Releases
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
·
20 min read
Press Releases
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
March 19, 2026
·
7 min read
Press Releases
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
May 26, 2026
·
8 min read
1 of 48,447
Next
